Cargando…

Cardiovascular disease in older women with CKD

Detalles Bibliográficos
Autores principales:	Radley, Alice, Lees, Jennifer S, Stevens, Kate I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689181/ https://www.ncbi.nlm.nih.gov/pubmed/38046012 http://dx.doi.org/10.1093/ckj/sfad235

Ejemplares similares

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Shedding a light on sex disparity in clinical trials in CKD patients
por: Mallamaci, Francesca, et al.
Publicado: (2023)

Blood pressure targets in CKD 2021: the never-ending guidelines debacle
por: Carriazo, Sol, et al.
Publicado: (2022)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Ensuring Indigenous co-leadership in health research: a Can-SOLVE CKD case example
por: Woods, Cathy, et al.
Publicado: (2023)

Magnesium and Cardiovascular Disease in CKD: The Mysteries of a Humble Divalent Cation
por: Kula, Alexander J., et al.
Publicado: (2021)

Fingertip digital thermal monitoring: a fingerprint for cardiovascular disease?
por: van der Wall, E. E., et al.
Publicado: (2009)

Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?
por: Floyd, Lauren, et al.
Publicado: (2022)

Klotho: a link between cardiovascular and non-cardiovascular mortality
por: Lanzani, Chiara, et al.
Publicado: (2020)

YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease
por: Schernthaner, Gerit-Holger, et al.
Publicado: (2016)

Is there any relationship between cardiopulmonary capacity and cardiovascular mechanics in coronary artery disease?
por: Tadic, Marijana, et al.
Publicado: (2016)

The urgent need of public policies for promoting cardiovascular health in Latin-American women
por: Seron, Pamela, et al.
Publicado: (2021)

Commentary: Increased Risk of Cardiovascular Disease in Restless Legs Syndrome Patients: A Call to Action
por: De Berardis, Domenico, et al.
Publicado: (2023)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Slicing Into Human Translational Cardiovascular Biology
por: Lavine, Kory J., et al.
Publicado: (2016)

Arterial function and cardiovascular risk in dialysis
por: Iorio, Biagio R Di, et al.
Publicado: (2015)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Should ethnicity be included in cardiovascular risk stratification?
por: Krenning, B. J., et al.
Publicado: (2014)

Pokémon Go: cardiovascular benefit or injury risk?
por: Sharma, Pranev, et al.
Publicado: (2016)

Asynchronous Shortening of Telomere Length and Cardiovascular Outcomes
por: Wang, Chao-Yung
Publicado: (2018)

The Detrimental Effects of Alcohol and Cannabinoids on Cardiovascular Function
por: Montecucco, Fabrizio, et al.
Publicado: (2019)

Cardiovascular changes in young renal failure patients
por: Tøndel, Camilla, et al.
Publicado: (2021)

Renal artery stenting in the correct patients with atherosclerotic renovascular disease: time for a proper renal and cardiovascular outcome study?
por: Theodorakopoulou, Marieta P, et al.
Publicado: (2022)

Untapped Potential for Female Patients? Comment on Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176
por: Kielb, Julia, et al.
Publicado: (2022)

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022)

The Time Is Now to Investigate Ventilator Settings in Acute Cardiovascular Patients
por: Miller, P. Elliott, et al.
Publicado: (2023)

Parkinson's disease in LGBT+ older adults: The unexplored connection
por: Scorza, Fulvio A., et al.
Publicado: (2023)

Cardiovascular health and disease in migrant populations: a call to action
por: Agyemang, Charles, et al.
Publicado: (2021)

Do We Understand Cardiovascular Issues in Children and Adolescents with Metabolic Syndrome?
por: Eun, Lucy Youngmin
Publicado: (2015)

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
por: Marx, Nikolaus, et al.
Publicado: (2018)

Trimethylamine-N-Oxide: The Link Between Loop Diuretics and Cardiovascular Outcomes?
por: Adel, Fadi W., et al.
Publicado: (2021)

Baseline proteinuria level and adverse outcomes in pregnant women with chronic kidney disease: new evidence and a note of caution
por: Kervella, Delphine, et al.
Publicado: (2023)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

Novel results and future perspectives of study of cardiovascular autonomic control in prediabetic patients
por: Kiselev, Anton R., et al.
Publicado: (2016)

Metabolic Acidosis and Cardiovascular Disease in CKD
por: Collister, David, et al.
Publicado: (2021)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Digital health interventions in chronic kidney disease: levelling the playing field?
por: Graham-Brown, Matthew P M, et al.
Publicado: (2022)

Bioimpedance in CKD: an untapped resource?
por: Mayne, Kaitlin J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2bukfhf64dap0brulqq5b22odv